Insiders Mesoblast Limited Nasdaq

Equities

MESO

US5907174016

Market Closed - Nasdaq Other stock markets 01:30:00 22/05/2024 am IST			5-day change	1st Jan Change
7.91 ^USD	+8.21%		+9.86%	+259.55%

01/04	ADRs End Higher; Connect Biopharma Climbs 26%	DJ
28/03	ADRs End Lower; NuCana Slides 15%	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pre-Holiday Data Slew Awaited as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Wednesday	22/11	MT
Mesoblast Limited Announces Cessation of Michael Spooner as Director	03/23/03	CI
Jane Bell AM Appointed Chair of Mesoblast Audit and Risk Committee	26/23/26	CI
Mesoblast Limited Appoints Philip R. Krause, Member of the Board of Directors, to Formal Strategic Advisory Role	05/23/05	CI
Mesoblast Limited Announces Board Changes	18/22/18	CI
Mesoblast Limited Announces Executive Changes	06/22/06	CI
Mesoblast Limited Appoints Philip R. Krause to its Board of Directors	24/22/24	CI
Donal O'Dwyer Retires from the Board of Mesoblast Limited	25/22/25	CI
Mesoblast Appoints Chief Medical Officer	02/22/02	MT
Mesoblast Names New Chief Medical Officer	02/22/02	MT
Mesoblast Limited Appoints Eric Rose as Chief Medical Officer	02/22/02	CI
Mesoblast Limited Appoints Philip J. Facchina to Its Board of Directors	29/21/29	CI
Mesoblast Limited Announces the Appointment of Dagmar Rosa-Bjorkeson to the Role of Chief Operating Officer, Based in New York	24/20/24	CI
US FDA Agrees to the Selection of Mesoblast Limited's Ryoncil as the Commercial Name for its Lead Allogeneic Cell Therapy Remestemcel-L in the Treatment of Pediatric Steroid-Refractory Acute Graft Versus Host Disease	15/20/15	CI
Mesoblast Limited Announces Appointment of Joint Company Secretary	29/19/29	CI
Mesoblast Limited Appoints Fred Grossman as Chief Medical Officer	12/19/12	CI
Mesoblast Limited Announces the Cessation of Brian Jamieson as Director Effective from 31 March 2019	05/19/05	CI
U.S. Healthcare Leader Joseph R. Swedish Appointed Mesoblast Chairman	23/19/23	GL
Mesoblast Limited Announces Board Changes	22/19/22	CI
Mesoblast Limited Appoints Eric Strati as Senior Vice President, Commercial	19/18/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Mesoblast Limited Nasdaq

Equities

MESO

US5907174016

Insiders

Filters